{"mainPropery":{"diseaseId":6961,"diseaseName":"Malaria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6961/malaria","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0024530"},{"identifierType":"MeSH","identifierId":"D008288"}]},"diseaseCategories":[{"diseaseTypeId":20,"diseaseTypeName":"Parasitic diseases"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=248310' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Malaria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Malaria%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Malaria. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/malaria.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicinehealth.com/malaria/article_em.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1538,"resourceId":2169,"resourceName":"MeSH®","descriptionText":"<a href='http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&index=7947&view=expanded' target='_blank'>MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1548,"resourceId":2176,"resourceName":"Centers for Disease Control and Prevention","descriptionText":"You can obtain information on this topic from the <a href='http://www.cdc.gov/malaria/' target='_blank'>Centers for Disease Control and Prevention</a> (CDC). The CDC is recognized as the lead federal agency for developing and applying disease prevention and control, environmental health, and health promotion and education activities designed to improve the health of the people of the United States.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1559,"resourceId":2185,"resourceName":"National Institute of Allergy and Infectious Diseases","descriptionText":"The <a href='http://www3.niaid.nih.gov/topics/Malaria/default.htm' target='_blank'>National Institute of Allergy and Infectious Diseases</a> (NIAID) supports scientists developing better ways to diagnose, treat, and prevent the many infectious, immunologic, and allergic diseases that afflict people worldwide.  Click on the link to view information on&nbsp;this topic.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":4492,"questionText":"What is malaria?","answerText":"<strong>Malaria</strong> is a serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. Infection with malaria parasites may result in a wide variety of symptoms, ranging from absent or very mild symptoms to severe disease and even death. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness. In general, malaria is a curable disease if diagnosed and treated promptly and correctly.&nbsp;Treatment depends on many factors including disease severity, the species of malaria parasite causing the infection and the part of the world in which the infection was acquired.[3452]","dateModified":"2011-05-12T11:06:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":454,"genericName":"Halofantrine","tradeName":"Halfan™ ","tradeLink":"","manufacturer":"GlaxoSmithKline","sponsor":"SmithKline Beecham Pharmaceuticals","indication":"Treatment of adults who can tolerate oral medication and who have mild to moderate malaria caused by Plasmodium falciparum or Plasmodium vivax.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?regno=069756532","medlinePlusLink":""},{"productId":735,"genericName":"Tafenoquine","tradeName":"Krintafel","tradeLink":"https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-krintafel-tafenoquine-for-the-radical-cure-of-p-vivax-malaria/","manufacturer":"","sponsor":"GlaxoSmithKline","indication":"July 2018, tafenoquine (Krintafel) was approved for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection.","drugInformationLink":"","medlinePlusLink":""},{"productId":252,"genericName":"Mefloquine HCl","tradeName":"Lariam ","tradeLink":"","manufacturer":"","sponsor":"Hoffmann-La Roche, Inc.","indication":"Treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax. Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?regno=051773923","medlinePlusLink":""},{"productId":35,"genericName":"Quinine sulfate","tradeName":"Qualaquin","tradeLink":"","manufacturer":"","sponsor":"AR Holding Company, Inc.","indication":"Treatment of uncomplicated Plasmodium falciparum malaria.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/qualaquin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a682322.html"}],"EncodedName":"Malaria"}